TOTAL              265
and                  Z5                  13 
Althea               Z99                 10 
technologies         Y1                   9 
of                   Z5                   9 
a                    Z5                   7 
development          A2.1+                6 
for                  Z5                   5 
inc                  I2.1                 4 
the                  Z5                   4 
Ajinomoto_Co.        Z1                   4 
in                   Z5                   4 
Ajinomoto_Co         Z1                   3 
manufacturing        A1.1.1               3 
services             S8+                  3 
about                Z5                   3 
product              O2                   3 
offers               A9-                  3 
formulation          G1.1                 3 
SAN_DIEGO            Z2                   2 
ajinomoto            Z99                  2 
TYO                  Z99                  2 
2802                 N1                   2 
at                   Z5                   2 
fully                A13.2                2 
operating            A1.1.1               2 
company              I2.1                 2 
Ajinomoto_Althea     Z1                   2 
is                   A3+                  2 
global               W3                   2 
food                 F1                   2 
human                S2                   2 
health               B2                   2 
billion              N1                   2 
more                 N5++                 2 
visit                S1.1.1               2 
release              A1.7-                2 
technology           Y1                   2 
that                 Z8                   2 
d--                  Z99                  1 
co.                  I2.1                 1 
have                 Z5                   1 
completed            T2-                  1 
previously           N4                   1 
announced            Q2.2                 1 
acquisition          A9+                  1 
leading              S7.1+                1 
provider             A9-                  1 
biopharmaceutical    Z99                  1 
logo                 C1                   1 
http                 I1                   1 
**49;7;toolong       Z99                  1 
acquired             A9+                  1 
all                  N5.1+                1 
capital              I1.1                 1 
stock                A9+                  1 
closing              A1.1.1               1 
purchase             I2.2                 1 
price                I1.3                 1 
approximately        A13.4                1 
$175_million         Z99                  1 
dollars              I1                   1 
USD                  Z99                  1 
will                 T1.1.3               1 
become               A2.1+                1 
consolidated         A7+                  1 
subsidiary           A11.1-               1 
inc.                 I2.1                 1 
under                Z5                   1 
name                 Q2.2                 1 
manufacturer         A1.1.1               1 
high-quality         A5.1+                1 
seasonings           F1                   1 
processed            O4.1                 1 
foods                F1                   1 
beverages            F2                   1 
amino_acids          O1                   1 
pharmaceuticals      B3                   1 
specialty            A4.2+                1 
chemicals            O1                   1 
for_many_decades     T1.3+                1 
has                  Z5                   1 
contributed          A9-                  1 
to                   Z5                   1 
culture              C1                   1 
through              Z5                   1 
wide-ranging         A6.3+                1 
application          Q1.2                 1 
amino_acid           O1                   1 
today                T1.1.2               1 
is                   Z5                   1 
becoming             A2.1+                1 
increasingly         A13.3                1 
involved             A1.8+                1 
with                 Z5                   1 
solutions            X4.2                 1 
improved             A5.1+                1 
resources            A9+                  1 
sustainability       T2++                 1 
founded              T2+                  1 
1909                 N1                   1 
now                  T1.1.2               1 
26                   N1                   1 
countries            M7                   1 
had                  A9+                  1 
net                  N5                   1 
sales                I2.2                 1 
JYP_1,197.3          Z2                   1 
USD_15.1             Z2                   1 
fiscal               I1                   1 
2011                 N1                   1 
www.ajinomoto.com    N3.3                 1 
integrated           A1.8+                1 
contract             I2.1                 1 
organization         S5+                  1 
located              M6                   1 
CA                   A7+                  1 
providing            A9-                  1 
clinical             B3                   1 
commercial           I2.1                 1 
cgmp                 I1                   1 
drug                 B3                   1 
filling_in           Q1.2                 1 
both                 Z5                   1 
vials                Z99                  1 
syringes             O2                   1 
production           A1.1.1               1 
microbial-derived    Z99                  1 
recombinant          Z99                  1 
proteins             O1                   1 
plasmid              Z99                  1 
dna                  B1                   1 
in_conjunction_with  S5+                  1 
these                Z8                   1 
operations           A1.1.1               1 
comprehensive        A1.8+                1 
including            A1.8+                1 
upstream             M6                   1 
downstream           N3.3++               1 
process              A1.1.1               1 
analytical           X2.4                 1 
lyophilization       Z99                  1 
cycle                M3                   1 
complex              A12-                 1 
ich-compliant        Z99                  1 
stability            A2.1-                1 
testing              P1                   1 
'                    Z5                   1 
platform             M3                   1 
includes             A1.8+                1 
Crystalomics         Z99                  1 
proprietary          A9+                  1 
solution             X4.2                 1 
large                N3.2+                1 
molecule             O1                   1 
products             O2                   1 
must                 S6+                  1 
be                   Z5                   1 
delivered            M2                   1 
high                 N3.7+                1 
concentrations       X5.1+                1 
or                   Z5                   1 
as                   A13                  1 
sustained            T2++                 1 
formulations         G1.1                 1 
information          X2.2+                1 
www.altheatech.com   N3.3                 1 
source               T2+                  1 
